Cervical Cancer Diagnostic Test Market To Record Impressive Growth, Revenue To Surge To US$ 9.46 Bn By 2021

31-Aug-2018 | Zion Market Research

With the presence of a large pool of participants, the global cervical cancer diagnostic test market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). QIAGEN N.V., Hologic Inc., Roche Diagnostic, Becton, Dickinson and Company, Quest Diagnostic, Inc., and Abbott Laboratories are some of the key vendors of cervical cancer diagnostic test across the world. These players across global cervical cancer diagnostic test market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the market study.

Citing an instance, in August 2018, QIAGEN declared that WHO has added its care HPVTM test, the only molecular diagnostic screening test that can be carried out for high risk HPV in females in low-resource settings, to the list of prequalified in vitro diagnostic. Analysts are of the view that the strategic move will intensify the development of cervical cancer diagnostic test market over the forthcoming years.

Request Sample Request Customization Buy Now

This review is based on a report by Zion Market Research, titled "Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others) for Hospitals, Laboratories and Other End-users - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”- Report at http://www.zionmarketresearch.com/report/cervical-cancer-diagnostic-test-market

As estimated in this report, the global cervical cancer diagnostic test market stood at US$ 6.70 billion in 2015. Witnessing a tremendous rise during the period from 2015 to 2021, the revenue in cervical cancer diagnostic test market is expected to reach US$ 9.46 billion by the end of the forecast period. The main test types available in cervical cancer diagnostic test market are Endocervical curettage, Pap smear tests, colposcopy, HPV testing, cone biopsy, and loop electrosurgical excision procedure. Among them, the demand for Pap smear tests is relatively higher and the trend is anticipated to remain so over the next few years, notes the research report.

Cervical Cancer Diagnostic Test

Changing Lifestyles And Weak Immunity In Females To Boost Market Growth

“Weakened immune system along with cancer history of the female patients related to cervical cancer type will enhance the popularity of cervical cancer diagnostic tests across the globe,” says the author of this study. Apart from this, lifestyle-associated aspects such as smoking, unsafe sexual relationships with HPV- positive persons, and many sex partners will further amplify the cervical cancer diagnostic test market demand in the near future.

Lack of education pertaining to occurrence of cervical cancer and the disinclination of the female population to go for diagnosis of cervical cancer, however, is predicted to adversely impact the growth of cervical cancer diagnostic test market over the years to come. Furthermore, prevention of HPV through vaccination can also restrict the cervical cancer diagnostic test market growth.

Advanced Screening Tests Availability to Help North American Dominance

Geographically, North America has been leading the worldwide cervical cancer diagnostic test market and is anticipated to continue on the dominant position in the years to come, states the market study. Easy access to technologically advanced computer-aided cancer screening tests is anticipated to steer the expansion of cervical cancer diagnostic test market in the years ahead. Furthermore, the presence of a well-established medical and healthcare infrastructure along with availability of skilled healthcare service providers is yet another factor behind the dominance of the North America cervical cancer diagnostic test market. The high number of market players being headquartered in North America will further magnify the progress of this cervical cancer diagnostic test market.

 The global cervical cancer diagnostic test market is segmented as follows:

By Test

  • Pap Smear Tests
  • Colposcopy
  • HPV Testing
  • Endocervical Curettage (ECC)
  • Others {Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)}

By End-User

  • Hospitals
  • Laboratories 
  • Others

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Browse The New Press Release At https://www.zionmarketresearch.com/news/cervical-cancer-diagnostic-test-industry

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Request Brochure
Latest Published Reports

View All Published Reports